NuVasive (Nasdaq:NUVA) shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The San Diego–based spine surgery tech company posted profits of $19.2 million, or 35¢ per share, on sales of $290.8 million for the three months ended March 31, 2022, for a massive bottom-line gain out of the red […]
Nuvasive
NuVasive announces positive data for its Simplify cervical disc
NuVasive (Nasdaq:NUVA) today announced data from an FDA investigational device exemption study supporting its Simplify cervical disc. San Diego-based NuVasive’s two-level FDA IDE study data was recently published in the Journal of Neurosurgery: Spine and utilized in the device’s FDA pre-market application for two-level indication approval, which NuVasive received in April 2021. The peer-reviewed publication includes […]
NuVasive reports mixed results in Q4
NuVasive (NASDAQ: NUVA) today reported fourth-quarter results that missed the Wall Street consensus on earnings but beat on revenue. The San Diego–based spine surgery tech company lost $36.7 million, or 71¢ per share, on sales of $302.1 million for the quarter ended Dec. 31, 2021 — versus a profit of $1.7 million, or 3¢ per […]
Nuvasive Attrax Putty wins FDA expanded clearance for use in thoracolumbar interbody procedures
Nuvasive today announced that its Attrax Putty received FDA 510(k) clearance for expanded indications in thoracolumbar interbody spine surgery. Attrax Putty is a synthetic, bioactive and osteoconductive bone void filler that drives bone fusion. San Diego–based Nuvasive designed it with a surface microarchitecture that has an optimized environment for bone formation without added cells or […]
Globus Medical could be eying NuVasive
Globus Medical (NYSE: GMED) has made an offer to acquire fellow spine surgery tech company NuVasive (Nasdaq:NUVA), according to Bloomberg and Reuters. Both media outlets cited people familiar with the matter during their reports yesterday. A NuVasive spokesperson had no comment when reached today by MassDevice. If it takes place, the deal would create one of […]
NuVasive to launch virtual reality training platform for spine surgery
NuVasive (NSDQ:NUVA) announced today that it will release a virtual reality (VR) training module for its NuVasive X360 system. San Diego–based NuVasive said in a news release that the launch of the cutting-edge training module complements its market-leading clinical professional development (CPD) program. The NuVasive X360 VR training module — developed in collaboration with PrecisionOS […]
NuVasive launches newest porous PEEK implant for posterior spine surgery
NuVasive (NSDQ:NUVA) announced today that it launched the Cohere TLIF-O porous PEEK implant for posterior spine surgery. San Diego-based NuVasive also confirmed a planned launch for its Cohere TLIF-A implant for later in the fourth quarter of this year. NuVasive said it is the only company to offer both porous PEEK and porous titanium implants […]
Medtronic, Johnson & Johnson warn of hospital worker burnout headwind
Medical device manufacturers are worried that the COVID-19 pandemic’s latest wave will make for a tougher recovery in elective procedures after Delta variant cases subside. Top officials from Medtronic (NYSE:MDT), Johnson & Johnson (NYSE:JNJ), NuVasive (NASDAQ: NUVA) and Zimmer Biomet Holdings (NYSE:ZBH) recently warned investors of the problem. The concern is that the highly contagious […]
NuVasive creates new C-level positions
NuVasive (NSDQ:NUVA) announced that it added chief commercial officer and chief technology officer as new executive leadership roles. Effective immediately, Massimo Calafiore will assume the position of chief commercial officer, while Ryan Donahoe was appointed as chief technology officer, with both reporting directly to CEO J. Christopher Barry. In connection with the new leadership structure, […]
NuVasive sales up 45% in Q2
NuVasive (NSDQ:NUVA) posted second-quarter results that beat the overall consensus on Wall Street. The San Diego-based spine surgery tech company reported profits of $1.8 million, or 3¢ per share, on sales of $294.8 million for the three months ended June 30. The results out yesterday evening marked an improvement from Q2 2020, when the company […]
Report: Medtech dollars, deals hit new highs in first half of 2021
Fueled at least in part by exceptionally strong IPO and M&A markets, hedge funds, venture capitalists, private equity firms and corporate investors are committing more time and money into privately held medical devices companies, according to a new “Healthcare Investments and Exits” report issued by Silicon Valley Bank. The report examining the first half of […]
